Enterin
0 followers
‌
Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease
Industries
Headquarters
Employees
Links
Org chart
Denise Barbut
Co-Founder, Chief Medical Officer & Board Member
Michael Zasloff
Co-Founder, Chief Scientific Officer & Board Member
William Kinney
Co-Founder & SVP of R&D
Richard S. Larson
Chief Medical Officer
Kimberly Man
Vice President Operations
D. Phillip Cox
VP Commercial Manufacturing
Constantine Ward
Global Head of Clinical Trial Supply
Jennifer Beezley
Associate Director, Clinical Trial Management
Christina Gallagher
Clinical Trials Logistics Manager
Hilde Williams
Senior Regulatory Advisor, Regulatory Strategy & Operations
Joseph Costa
Financial Controller
